Harnessing Meta-analysis to Refine an Oncology Patient Population for Physiology-Based Pharmacokinetic Modeling of Drugs.

about

Modeling Drug Disposition and Drug-Drug Interactions Through Hypothesis-Driven Physiologically Based Pharmacokinetics: a Reversal Translation Perspective.Development, Verification, and Prediction of Osimertinib Drug-Drug Interactions Using PBPK Modeling Approach to Inform Drug Label.

P2860

Q50076374-5BD13843-FE40-4C90-A90F-D528B5069B95 Q55080883-0BC5DF62-500F-43E5-AA4B-E8A55EC4E555

P2860

Harnessing Meta-analysis to Refine an Oncology Patient Population for Physiology-Based Pharmacokinetic Modeling of Drugs.

Item

http://www.wikidata.org/entity/Q50074569

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Harnessing Meta-analysis to Re ...... macokinetic Modeling of Drugs.

@en

Harnessing Meta-analysis to Re ...... macokinetic Modeling of Drugs.

@nl

type

Item

label

Harnessing Meta-analysis to Re ...... macokinetic Modeling of Drugs.

@en

Harnessing Meta-analysis to Re ...... macokinetic Modeling of Drugs.

@nl

prefLabel

Harnessing Meta-analysis to Re ...... macokinetic Modeling of Drugs.

@en

Harnessing Meta-analysis to Re ...... macokinetic Modeling of Drugs.

@nl

P1476

Harnessing Meta-analysis to Re ...... macokinetic Modeling of Drugs.

@en

P2093

Emily Schwenger

http://www.w3.org/2001/XMLSchema#string

Eric Masson

http://www.w3.org/2001/XMLSchema#string

Ganesh Moorthy

http://www.w3.org/2001/XMLSchema#string

Helen Tomkinson

http://www.w3.org/2001/XMLSchema#string

Karthick Vishwanathan

http://www.w3.org/2001/XMLSchema#string

Pradeep Sharma

http://www.w3.org/2001/XMLSchema#string

Venkatesh Pilla Reddy

http://www.w3.org/2001/XMLSchema#string

P2860

A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities

Meta-analysis in clinical trials

Management of dose variability and side effects for individualized cancer pharmacotherapy with tyrosine kinase inhibitors

The Simcyp population-based ADME simulator

Oxidative stress, inflammation, and cancer: how are they linked?

Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response.

Efficient estimation of log-normal means with application to pharmacokinetic data.

Modulation of irinotecan metabolism by ketoconazole.

Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data.

Impact of physiologically based pharmacokinetic models on regulatory reviews and product labels: Frequent utilization in the field of oncology

P304

271-280

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1002/CPT.917

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29063606

http://www.w3.org/2001/XMLSchema#string

Harnessing Meta-analysis to Refine an Oncology Patient Population for Physiology-Based Pharmacokinetic Modeling of Drugs.

about

P2860

P2860

Harnessing Meta-analysis to Refine an Oncology Patient Population for Physiology-Based Pharmacokinetic Modeling of Drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698